FDA NDC Directory · JSON-LD · Markdown

isatuximab

NDC 12854-659 · DRUG FOR FURTHER PROCESSING · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerSanofi-Aventis Deutschland GmbH
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE
Active ingredientsISATUXIMAB (1400 mg/10mL)
Marketing started20260709
Package count1

External sources

Source: openFDA. Public-domain (CC0).